ABSTRACT
A 15-year-old spayed female mongrel presented with anorexia and an abdominal mass. The mass originated from the gall bladder and was surgically resected along with divisionectomy of the central hepatic division. Paroxysmal hypertension and tachycardia were noted during manipulation of the mass. Following resection, arterial blood pressure decreased significantly. Histopathological analysis confirmed a diagnosis of neuroendocrine neoplasm. Immunohistochemical staining for synaptophysin and chromogranin A yielded diffuse and strong positive results, while gastrin was positive in only 10% of the cells. The preoperative elevated concentrations of catecholamine in the urinalysis showed a marked decrease after surgery. Based on these findings, the tumour was diagnosed as a functional paraganglioma of the gall bladder. The patient has undergone regular thoracic radiographs and ultrasound examinations and, until 431 days after surgery, has shown no signs of metastases or recurrences. Based on our literature search, we report the first case of functional paraganglioma of the gall bladder in a dog.
Subject(s)
Dog Diseases , Hypertensive Crisis , Paraganglioma , Urinary Bladder Neoplasms , Humans , Dogs , Female , Animals , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder Neoplasms/pathology , Urinary Bladder Neoplasms/surgery , Urinary Bladder Neoplasms/veterinary , Hypertensive Crisis/veterinary , Gallbladder/pathology , Paraganglioma/complications , Paraganglioma/diagnosis , Paraganglioma/surgery , Paraganglioma/veterinary , Catecholamines , Dog Diseases/diagnosis , Dog Diseases/surgeryABSTRACT
Gallbladder mucocele (GM) is a common extrahepatic biliary disease recognized in dogs and is defined as the expansion and extension of the gallbladder by an accumulation of semi-solid bile or bile acid. Histopathological diagnosis of necrotizing cholecystitis and transmural coagulative necrosis of the gallbladder wall shows poor prognosis. Conversely, histopathological diagnosis with partial necrotic findings is often achieved. We hypothesized that histopathological partial necrosis of the gallbladder wall is the primary lesion of necrotic cholecystitis or transmural ischemic necrosis. Therefore, we investigated the relationship between histopathological necrosis/ partial necrosis findings and their clinical conditions. We retrospectively analyzed 55 dogs diagnosed with GM that had undergone cholecystectomy at the Yamaguchi University Animal Medical Center. The group with histopathological necrosis/partial necrosis of the gallbladder wall showed elevated levels of preoperative white blood cells, alanine transaminase, alkaline phosphatase, γ-glutamyltransferase, total bilirubin, and C-reactive protein compared to the non-necrotic group. Partial necrosis of the gallbladder wall may affect the progression of the disease and hematological abnormalities. Additionally, all death cases until 2 weeks were included in the histopathological necrosis/partial necrosis group. In this study, we found that poor prognosis factors were associated with partial necrosis of the gallbladder wall. Furthermore, these cases of partial necrosis showed elevated levels of blood test parameters. These results suggest that necrosis of the gallbladder wall is associated with poor prognosis and poor pathophysiological conditions.
Subject(s)
Cholecystitis , Dog Diseases , Gallbladder Diseases , Mucocele , Animals , Cholecystitis/complications , Cholecystitis/veterinary , Dog Diseases/pathology , Dogs , Gallbladder Diseases/complications , Gallbladder Diseases/surgery , Gallbladder Diseases/veterinary , Humans , Mucocele/complications , Mucocele/pathology , Mucocele/veterinary , Necrosis/complications , Necrosis/veterinary , Retrospective StudiesABSTRACT
Oncolytic virotherapy is a novel treatment involving replication-competent virus in the elimination of cancer. We have previously reported the oncolytic effects of reovirus in various canine cancer cell lines. This study aims to establish the safety profile of reovirus in dogs with spontaneously occurring tumours and to determine a recommended dosing regimen. Nineteen dogs with various tumours, mostly of advanced stages, were treated with reovirus, ranging from 1.0 × 108 to 5.0 × 109 TCID50 given as intratumour injection (IT) or intravenous infusion (IV) daily for up to 5 consecutive days in 1 or multiple treatment cycles. Adverse events (AEs) were graded according to the Veterinary Cooperative Oncology Group- Common Terminology Criteria for Adverse Events (VCOG-CTCAE) v1.1 guidelines. Viral shedding, neutralizing anti-reovirus antibody (NARA) production and immunohistochemical (IHC) detection of reovirus protein in the tumours were also assessed. AE was not observed in most dogs and events were limited to Grade I or II fever, vomiting, diarrhoea and inflammation of the injected tumour. No infectious virus was shed and all dogs had elevated NARA levels post-treatment. Although IHC results were only available in 6 dogs, 4 were detected positive for reovirus protein. In conclusion, reovirus is well-tolerated and can be given safely to tumour-bearing dogs according to the dosing regimen used in this study without significant concerns of viral shedding. Reovirus is also potentially effective in various types of canine tumours.
Subject(s)
Dog Diseases/drug therapy , Dog Diseases/immunology , Neoplasms/veterinary , Oncolytic Virotherapy/veterinary , Oncolytic Viruses/immunology , Reoviridae/immunology , Animals , Antibodies, Neutralizing/blood , Antineoplastic Agents/immunology , Antineoplastic Agents/pharmacology , Dogs , Female , Japan , Male , Neoplasms/drug therapy , Neoplasms/immunology , Oncolytic Virotherapy/methods , Pilot Projects , Polymerase Chain Reaction , Schools, Veterinary , Treatment Outcome , Virus SheddingABSTRACT
A 3-month-old male Japanese cat with feline parvovirus infection, showing central and cervical nerve abnormalities, was diagnosed as hydrocephalus and syringomyelia by use of magnetic resonance imaging (MRI). The cat was maintained clinically by medical treatment even though he could not stand. The MRI scans obtained about 5 months later showed that the ventricles had increased in size and the cervical syrinx had extended into the thoracic spinal cord. Ventriculoperitoneal (VP) shunt was performed. One week after surgery, neurological conditions had improved. At the postoperative MR images, the ventricles had decreased in size and the syrinx in the cervical and thoracic spinal cord could no longer be seen. The cat was still alive and was able to walk well.
Subject(s)
Cat Diseases/diagnosis , Hydrocephalus/veterinary , Syringomyelia/veterinary , Ventriculoperitoneal Shunt/veterinary , Animals , Cat Diseases/therapy , Cats , Diuretics/therapeutic use , Furosemide/therapeutic use , Hydrocephalus/diagnosis , Hydrocephalus/therapy , Magnetic Resonance Imaging/veterinary , Male , Syringomyelia/diagnosis , Syringomyelia/therapyABSTRACT
This is a report of an accidental breakaway of a microcatheter during endovascular embolization for cerebral arteriovenous malformation occurring in a 48-year-old female. She had a sudden onset of cerebral herniated signs caused by a large hemorrhage in the region of the right parietal lobe. An angiogram showed a large arteriovenous malformation in the same region. 48 days after emergency evacuation of the hematoma and clipping of a feeding artery, we performed endovascular embolization using a microcatheter as assistant therapy for total removal of the nidus. However, accidentally, the microcatheter broke and migrated to the distal middle cerebral artery. Although we tried to retrieve the catheter using a loop snare, we had no success. We eventually retrieved it by open surgery next day. Fortunately the migrated catheter could be seen through a cortical artery, so after trapping it by using elastic thread and cutting off the artery we were able to extract the migrated catheter. Finally we were able to remove the nidus totally without other complications. Since breaking and migration of a microcatheter is a rare but possible accident, we should be prepared to cope with it appropriately.
Subject(s)
Catheterization/instrumentation , Embolization, Therapeutic/instrumentation , Foreign-Body Migration/surgery , Catheterization/adverse effects , Equipment Failure , Female , Foreign-Body Migration/diagnostic imaging , Humans , Intracranial Arteriovenous Malformations/therapy , Middle Aged , RadiographyABSTRACT
A rare case of metastatic choriocarcinoma with cerebral thrombosis and subsequent neoplastic aneurysm formation and rupture is reported. Three months after normal pregnancy and normal delivery, a 16-year-old woman was admitted with the chief complaints of speech disturbance and paresthesia of her right upper extremity on June 4, 1992. Both CT and MRI demonstrated cerebral infarction in the left insula. A cerebral angiogram revealed that the left middle cerebral artery (about 2 mm in diameter) was occluded in the distal M2 segment. On the 34th day, a follow up angiogram demonstrated a fusiform aneurysm at the same point of the arterial occlusion that had been already recanalized. On the 37th day, she suddenly had severe headaches and consciousness disturbance. CT showed subarachnoid hemorrhage. Resection of the aneurysm and left STA-MCA anastomosis were performed. Histological examination revealed that the aneurysmal walls were invaded by choriocarcinoma. On the 60th day, she was transferred to the department of obstetrics and gynecology for chemotherapy. On the 65th day and the 71st day, the patient suffered from intracerebral hemorrhage in the left basal ganglia, which originated from a different point of aneurysmectomy. She died because of the rapid growth of liver metastases 7 months after initial admission. Because chest CT and roentgenogram detected no lesion in the lungs, neoplastic embolus was unlikely as a cause of occlusion of the cerebral artery of about 2 mm in diameter. It would be more reasonable to believe that choriocarcinoma metastasized to the cerebral arterial walls initially and formed a thrombus which occluded the artery. As the neoplastic invasion weakened the arterial wall, a fusiform aneurysm was formed when the vessel was recanalized. There has been no case reported in the literature of neoplastic aneurysms of choriocarcinoma in which the course from aneurysmal formation to rupture was followed angiographically.
Subject(s)
Aneurysm, Ruptured/etiology , Brain Neoplasms/secondary , Choriocarcinoma/secondary , Intracranial Aneurysm/etiology , Intracranial Embolism and Thrombosis/etiology , Adolescent , Aneurysm, Ruptured/diagnostic imaging , Brain Neoplasms/diagnostic imaging , Cerebral Angiography , Choriocarcinoma/diagnostic imaging , Fatal Outcome , Female , Humans , Intracranial Aneurysm/diagnostic imaging , Intracranial Embolism and Thrombosis/diagnostic imaging , Liver Neoplasms/secondary , Neoplastic Cells, Circulating , Pregnancy , Pregnancy Complications, Neoplastic , Uterine Neoplasms/pathologyABSTRACT
Recent improvement of MRI has enabled us to clearly visualize intramedullary spinal lesions which previously could not be recognized by CT scan or myelography. We reported a case of hematomyelia caused by intramedullary cavernous hemangioma. In this case, MRI was very useful in efforts to recognize the lesions. With the use of MRI, we will be able to accurately ascertain the location and characteristics of intramedullary spinal lesions. The number of surgically treated cases of idiopathic hematomyelia will increase in the future.
Subject(s)
Hemangioma, Cavernous/complications , Hemorrhage/diagnosis , Magnetic Resonance Imaging , Spinal Cord Diseases/diagnosis , Spinal Cord Neoplasms/complications , Hemorrhage/etiology , Humans , Male , Middle Aged , Spinal Cord Diseases/etiologyABSTRACT
The authors assessed proton magnetic resonance spectroscopy (1H-MRS) in patients with unilateral refractory temporal bole epilepsy. The subjects consisted of 20 patients (those with brain tumors, trauma, malformations or definite organic lesions were excluded) and 10 normal volunteers. 1H-MRS and MRI were performed using a 1.5 tesla machine. 1H-MRS was achieved using point-resolved spectroscopy (PRESS) or the stimulated echo acquisition mode (STEAM), and a 3 x 3 x 3 cm volume of interest was positioned at the hippocampus. N-Acetyl-aspartate (NAA) and choline-containing substance (Cho) signals were evaluated. The results showed decreased NAA and elevated Cho or asymmetry of both NAA and Cho in the epileptogenic focus in 19/20 cases. The reductions in NAA presumably reflect neuronal loss, while the elevation of Cho probably represents membrane break down within the lesion. These abnormalities were observed in 19/20 cases (95%), whereas abnormal magnetic resonance imaging was detected in only 6/20 (30%) of the patients. Thus, 1H-MRS appears to be a useful, non-invasive modality for evaluating metabolic changes in epileptogenic foci, and these metabolic changes can serve as a more sensitive indicator than magnetic resonance imaging.
Subject(s)
Epilepsy, Temporal Lobe/diagnosis , Magnetic Resonance Spectroscopy/methods , Adolescent , Adult , Brain/metabolism , Brain/pathology , Child , Epilepsy, Temporal Lobe/metabolism , Epilepsy, Temporal Lobe/pathology , Female , Humans , Magnetic Resonance Imaging , Male , Middle AgedSubject(s)
Babesiosis/veterinary , DNA, Protozoan/analysis , Dog Diseases/diagnosis , Parasitemia/veterinary , Polymerase Chain Reaction/veterinary , Animals , Babesia/chemistry , Babesia/genetics , Babesia/isolation & purification , Babesiosis/blood , Babesiosis/diagnosis , Dog Diseases/blood , Dogs , Parasitemia/diagnosis , Physical Examination/veterinary , Polymerase Chain Reaction/methods , Sensitivity and Specificity , Severity of Illness IndexABSTRACT
MR angiography studies using the presaturation technique were performed in 7 patients who had received extra-intracranial (EC-IC) bypass surgery. With presaturation on the bypass vessels, disappearance of intracranial vascular signals suggests bypass effect. In our studies, good bypass effect was shown in 3 cases and poor effect in 2 cases, which correlates well to concurrent angiography. In two cases, bypass effect was shown only in a few cortical branches of MCA, but angiography confirmed recanalization of occluded internal carotid artery in one case, and growth of large network of transdural anastomoses in the other.
Subject(s)
Cerebral Revascularization , Cerebrovascular Circulation/physiology , Adult , Aged , Female , Humans , Magnetic Resonance Imaging , Male , Middle AgedABSTRACT
The anaesthetic and cardiopulmonary effects of combinations of medetomidine (Me), midazolam (Mi) and butorphanol (Bu) were evaluated in dogs. The characterization of anaesthetic effects was assessed using a scoring system. The combinations tested were 20 or 40 micrograms/kg Me and 0.5 mg/kg Mi (20Me-Mi or 40Me-Mi) followed by either an intravenous injection of physiological saline solution (PSS) or Bu (0.1 or 0.3 mg/kg). The mixture of Me and Mi was injected intramuscularly, followed 15 min later by an intravenous injection of Bu or PSS in all six groups. The combined Me-Mi induced deep sedation but not profound anaesthesia. The effect of the subsequent Bu administration was observed in the scores related to its analgesic effect. There were no significant differences between the two doses of Bu, following either 20Me-Mi or 40Me-Mi in the duration of anaesthesia, heart and respiratory rates, rectal temperature, and anaesthetic and analgesic scores except for palpebral reflex, and interdigital web clamping scores. Therefore, we concluded that the addition of 0.1 mg/kg Bu to Me-Mi elicits adequate anaesthesia with adequate analgesic effect, and side-effects such as bradycardia, hypertension, and slight respiratory acidosis in some dogs.
Subject(s)
Adrenergic alpha-Agonists , Analgesics, Opioid , Anesthetics, Combined , Butorphanol , Dogs/physiology , Hypnotics and Sedatives , Medetomidine , Midazolam , Animals , Blood Gas Analysis/veterinary , Blood Pressure , Body Temperature , Female , Heart Rate , Hydrogen-Ion Concentration , Male , Pain Measurement/veterinary , Random Allocation , Statistics, NonparametricABSTRACT
This study was designed to characterize the effect of medetomidine (Med) on canine electroencephalography (EEG), to evaluate the use of quantitative EEG for assessing sedation levels and to explore the correlation between the serum concentration of Med and the quantitative EEG. Four groups of dogs were given Med at doses of 20, 40, 80 and 160 microg/kg (Med-20, Med-40, Med-80 and Med-160 groups). Following Med administration, there was synchrony between each unipolar EEG lead. On EEG power spectrum analysis of the bipolar leads, all groups showed a significant depression of the 14-30 Hz components. The power of the 1-3 Hz component in the Med-80 and Med-160 groups was significantly increased, although there were few changes in the other groups. Similar results were obtained from raw data analysis. As a result of quantitative EEG analysis, spectrum edge frequency 90 analysis (SEP90) showed that the frequency was significantly reduced in all groups after Med administration. A dose-response effect was observed in all groups except for the Med-160 group. Both of these EEG analyses were significantly correlated with the serum concentration of Med. However, the result of the SPF90 analysis sugested a stronger correlation than that for median edge frequency analysis. In conclusion, care must be taken in veterinary clinical diagnoses when Med is used during EEG recording, as Med may cause increased activity in the low frequency band and a decrease in high frequency band activity. In addition, quantitative EEG analysis may be useful in assessing the depth of sedation and in further studies on Med administration.
Subject(s)
Dogs/physiology , Electroencephalography/veterinary , Hypnotics and Sedatives/pharmacology , Medetomidine/pharmacology , Anesthesia/veterinary , Animals , Cross-Over Studies , Dogs/blood , Dose-Response Relationship, Drug , Electroencephalography/drug effects , Electroencephalography/methods , Female , Hypnotics and Sedatives/administration & dosage , Injections, Intramuscular/veterinary , Male , Medetomidine/administration & dosage , Medetomidine/blood , Time FactorsABSTRACT
The purpose of this study was to evaluate the effects of the administration of an alpha2-adrenoceptor agonist alone and in combination with other derivatives on brain wave activity. In addition, the diagnostic values of the electroencephalogram (EEG) for judging the depth of the balanced anaesthesia with an alpha2-adrenoceptor agonist was evaluated. The treatments comprised 20 microg/kg medetomidine (Me-20), 80 microg/kg medetomidine (Me-80), 20 microg/kg medetomidine and 0.5 mg/kg midazolam (Me-Mi) administered intramuscularly, and 20 microg/kg medetomidine with 0.5 mg/kg midazolam and 0.1 mg/kg butorphanol (Me-Mi-Bu). The EEG was recorded continuously at pre-administration, and at 7, 10, 20, 30, 45 and 60 min after administration. The recorded data were analysed by separating the power spectrum into 1-3, 4-7, 8-13 and 14-30 Hz bands. Spectral-edge analysis was used to calculate the spectral edge frequency 90 (SEF90) and the median edge frequency (MEF). Time-related changes in power spectrum analysis showed a significant increase in the Me-80 group in the 1-3 Hz band. The power for 1-3 Hz in the Me-80 group was significantly higher than in all the other groups. In the 14-30 Hz band, there was a significant reduction of power in all groups following administration of the agents. The SEF90 frequencies were significantly reduced in all groups except for the Me-20 group after administration of the agents. The SEF90 frequencies in the Me-20, Me-Mi and Me-Mi-Bu were all significantly higher than those in the Me-80 group. However, there was no significant difference between the Me-20, Me-Mi and Me-Mi-Bu groups in any analyses. Our results demonstrated that the changes in quantitative EEG made by the Me-Mi-Bu and Me-Mi groups were similar to those made by Me-20 groups. Present results suggest that the EEG should be interpreted with caution in assessing the anaesthetic level in balanced anaesthesia in dogs.
Subject(s)
Adrenergic alpha-Agonists/pharmacology , Analgesics, Opioid/pharmacology , Brain/drug effects , Butorphanol/pharmacology , Dogs/physiology , Hypnotics and Sedatives/pharmacology , Medetomidine/pharmacology , Midazolam/pharmacology , Anesthesia/veterinary , Animals , Brain/physiology , Dose-Response Relationship, Drug , Electroencephalography/drug effects , Electroencephalography/methods , Electroencephalography/veterinary , Female , Injections, Intramuscular/veterinary , Kinetics , MaleABSTRACT
The case of a 56-year-old male with a schwannoma in the right psoas muscle is reported. The tumour was extirpated by the retroperitoneal approach, which afforded direct access to this lumbar paraspinal lesion.
Subject(s)
Neurilemmoma/surgery , Psoas Muscles/surgery , Retroperitoneal Neoplasms/surgery , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neurilemmoma/diagnosis , Psoas Muscles/pathology , Retroperitoneal Neoplasms/diagnosis , Retroperitoneal Space/surgeryABSTRACT
To understand the molecular mechanisms underlying normal and abnormal development of two salmonids, masu salmon (Oncorhynchus masou) and rainbow trout (O. mykiss), we used two-dimensional (2-D) electrophoresis to construct a series of 2-D maps during the embryonic period. We identified all visible protein spots on the 2-D map by assigning numbers for masu salmon and rainbow trout, and we determined N-terminal sequences of proteins for one hundred of the spots, that appear at very high concentrations in the whole embryos of masu salmon and rainbow trout. We also characterized embryonic stages according to the periods of appearance of spots. Most of the N-terminal sequences were identical or at least highly similar to partial sequences reported for vitellogenin (Vtg) of O. mykiss. A potential proteolytic processing of Vtg for rainbow trout is discussed in relation to the time of appearance and relative position of Vtg fragments within the complete protein sequence.
Subject(s)
Oncorhynchus/embryology , Proteins/metabolism , Proteome/metabolism , Amino Acid Sequence , Animals , Electrophoresis, Gel, Two-Dimensional/methods , Endopeptidases/metabolism , Molecular Sequence Data , Oncorhynchus/metabolism , Peptide Mapping/methods , Protein Processing, Post-TranslationalABSTRACT
AIMS/HYPOTHESIS: Dysfunctions of lipoprotein lipase (LPL) have been found to be associated with dyslipidaemias, atherosclerosis, obesity and insulin resistance. There are two conflicting hypotheses regarding the roles of LPL in glucose metabolism and insulin resistance. Whether systemically increased LPL activity would be beneficial or detrimental to insulin sensitivity is yet to be resolved. To address this issue, we studied transgenic rabbits overexpressing human LPL transgene. METHODS: LPL transgenic and control rabbits were fed a 10% high-fat diet (HFD) for 16 weeks. To evaluate glucose metabolism, we compared plasma levels of glucose and insulin in transgenic rabbits with control rabbits and performed an intravenous glucose tolerance test. In addition, we measured adipose tissue accumulation in HFD-fed rabbits. RESULTS: Increased LPL activity in transgenic rabbits resulted in a significant reduction of plasma triglycerides and non-esterified fatty acids, but not in basal levels of glucose and insulin. HFD feeding induced an elevation of plasma glucose levels accompanied by hyperinsulinaemia in control rabbits, but was significantly inhibited in transgenic rabbits. The intravenous glucose tolerance test showed that transgenic rabbits had faster glucose clearance associated with lower levels of insulin secretion than control rabbits. In addition, there was a significant reduction of body adipose tissue in transgenic rabbits compared with in control rabbits fed an HFD. Scanning electron microscopic examination revealed that adipocytes in transgenic rabbits were predominately small cells. CONCLUSIONS/INTERPRETATION: Our results showed that systemically increased LPL activity improves insulin resistance and reduces adipose accumulation in transgenic rabbits, indicating that systemic elevation of LPL may have potential benefits for the treatment of insulin resistance and obesity.